Update on botulinum toxin

被引：22

作者：

Flynn, Timothy Corcoran ^{[1
]}

机构：

[1] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA

来源：

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY | 2006年 / 25卷 / 03期

关键词：

D O I：

10.1016/j.sder.2006.06.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Botulinum toxin for facial enhancement is currently the most popular aesthetic procedure performed in the United States. New developments have occurred within the last few years. Patients prefer having multiple areas of the upper face treated which increases patient satisfaction. Treatment of the forehead is now being accomplished with fewer units of botulinum toxin. This helps preserve the natural look of some movement of the forehead. Men require more units of botulinum toxin than women. Combination therapy using botulinum toxin along with lasers or filler substances is ideal. Aesthetic medicine knowledge has progressed, contributing a greater understanding of botulinum treatment for advanced areas of the face. The orbicularis oris, mentalis, and depressor anguli oris are now routinely treated and help improve overall facial appearance. Other forms of botulinum toxins (additional type A or type B toxins) are available, each with advantages and disadvantages.

引用

页码：115 / 121

页数：7

共 35 条

[1] Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study [J].

Albani, G ;

Petroni, ML ;

Mauro, A ;

Liuzzi, A ;

Lezzi, G ;

Verti, B ;

Marzullo, P ;

Cattani, L .

JOURNAL OF GASTROENTEROLOGY, 2005, 40 (08) :833-835

[2] A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines [J].

Ascher, B ;

Zakine, B ;

Kestemont, P ;

Baspeyras, M ;

Bougara, A ;

Santini, J .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) :223-233

[3]

Ascher Benjamin, 2002, J Cosmet Laser Ther, V4 Suppl 1, P1

[4]

Balikian Richard V, 2005, Facial Plast Surg Clin North Am, V13, P583, DOI 10.1016/j.fsc.2005.06.004

[5]

Beer Kenneth, 2005, J Drugs Dermatol, V4, P417

[6] Comparative evaluation of the safety and efficacy of botulinum toxin type A and treating moderate-to-severe topical creams for glabellar rhytids [J].

Beer, KR .

DERMATOLOGIC SURGERY, 2006, 32 (02) :184-192

[7] Botulinum neurotoxin for the treatment of migraine and other primary headache disorders [J].

Blumenfeld, AM ;

Dodick, DW ;

Silberstein, SD .

DERMATOLOGIC CLINICS, 2004, 22 (02) :167-+

[8]

Bosniak Stephen, 2005, Ophthalmol Clin North Am, V18, P215, DOI 10.1016/j.ohc.2005.03.004

[9] Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids [J].

Carruthers, A ;

Carruthers, J .

DERMATOLOGIC SURGERY, 2005, 31 (10) :1297-1303

[10]

CARRUTHERS A, IN PRESS DERMATOL SU

← 1 2 3 4 →